P2.13-41 a Novel Mitochondria-Based Targeting to Restore Therapeutic Response in Cisplatin- And Gefitinib-Resistant Human Lung Cancer Cells

Journal of Thoracic Oncology - United States
doi 10.1016/j.jtho.2018.08.1436
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Phospholipids of Tumor Extracellular Vesicles Stratify Gefitinib-Resistant Nonsmall Cell Lung Cancer Cells From Gefitinib-Sensitive Cells

Proteomics
BiochemistryMolecular Biology
2015English

Exploiting ROS and Metabolic Differences to Kill Cisplatin Resistant Lung Cancer

Oncotarget
Oncology
2017English

Synergistic Effect of Afatinib With Su11274 in Non-Small Cell Lung Cancer Cells Resistant to Gefitinib or Erlotinib

PLoS ONE
Multidisciplinary
2013English

P2.13-34 Long Intergenic Non-Coding RNA 00665 Induces Acquired Resistance to Gefitinib in Non-Small-Cell Lung Cancer

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Role of FBXW7 in the Quiescence of Gefitinib-Resistant Lung Cancer Stem Cells in EGFR-mutant Non-Small Cell Lung Cancer

Bosnian Journal of Basic Medical Sciences
Medicine
2019English

Triclosan Potentiates Epithelial-To-Mesenchymal Transition in Anoikis-Resistant Human Lung Cancer Cells

PLoS ONE
Multidisciplinary
2014English

MicroRNA-182 Modulates Chemosensitivity of Human Non-Small Cell Lung Cancer to Cisplatin by Targeting PDCD4

Diagnostic Pathology
Forensic MedicineMedicinePathologyHistology
2014English

Bioenergetics of Acquired Cisplatin Resistant H1299 Non-Small Cell Lung Cancer and P31 Mesothelioma Cells

Oncotarget
Oncology
2017English

Targeting Cancer Stem Cells in Castration-Resistant Prostate Cancer

Clinical Cancer Research
Cancer ResearchOncology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy